Vectivbio

Developer of transformative therapeutics for rare diseases

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2019 groups42 employees language vectivbio.com

Social engagement

Social engagement: 33.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Versant Ventures, Orbimed, Novo Holdings, Bpifrance; 2 have since exited.

Investor typeCountShare
Venture capital750%
Bank & private debt214%
Other / undisclosed536%

Recent activity

1 May 2026
Event
DDW2026
Coming soon